View in EDS

Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.

Saved in:
Bibliographic Details
Title: Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.
Authors: Dassen MG; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Tree AC; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Wiersema L; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Neijndorff B; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Ruiter P; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Linden J; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mitchell A; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Dunlop A; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Alexander S; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Breitkreutz DY; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada., Cooper S; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Janssen T; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Pos F; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vesprini D; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada., van der Heide UA; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: u.vd.heide@nki.nl.
Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2026 May 01; Vol. 125 (1), pp. 257-265. Date of Electronic Publication: 2025 Nov 26.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41314554
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dassen+MG%22">Dassen MG</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tree+AC%22">Tree AC</searchLink>; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wiersema+L%22">Wiersema L</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Neijndorff+B%22">Neijndorff B</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Ruiter+P%22">de Ruiter P</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Linden+J%22">van der Linden J</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mitchell+A%22">Mitchell A</searchLink>; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dunlop+A%22">Dunlop A</searchLink>; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Alexander+S%22">Alexander S</searchLink>; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Breitkreutz+DY%22">Breitkreutz DY</searchLink>; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Cooper+S%22">Cooper S</searchLink>; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Janssen+T%22">Janssen T</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pos+F%22">Pos F</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vesprini+D%22">Vesprini D</searchLink>; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22van+der+Heide+UA%22">van der Heide UA</searchLink>; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: u.vd.heide@nki.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603616%22">International journal of radiation oncology, biology, physics</searchLink> [Int J Radiat Oncol Biol Phys] 2026 May 01; Vol. 125 (1), pp. 257-265. <i>Date of Electronic Publication: </i>2025 Nov 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603616 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-355X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203603016%22">03603016 </searchLink><i>NLM ISO Abbreviation: </i>Int J Radiat Oncol Biol Phys <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41314554
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijrobp.2025.11.028
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 257
    Titles:
      – TitleFull: Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dassen MG
      – PersonEntity:
          Name:
            NameFull: Tree AC
      – PersonEntity:
          Name:
            NameFull: Wiersema L
      – PersonEntity:
          Name:
            NameFull: Neijndorff B
      – PersonEntity:
          Name:
            NameFull: de Ruiter P
      – PersonEntity:
          Name:
            NameFull: van der Linden J
      – PersonEntity:
          Name:
            NameFull: Mitchell A
      – PersonEntity:
          Name:
            NameFull: Dunlop A
      – PersonEntity:
          Name:
            NameFull: Alexander S
      – PersonEntity:
          Name:
            NameFull: Breitkreutz DY
      – PersonEntity:
          Name:
            NameFull: Cooper S
      – PersonEntity:
          Name:
            NameFull: Janssen T
      – PersonEntity:
          Name:
            NameFull: Pos F
      – PersonEntity:
          Name:
            NameFull: Vesprini D
      – PersonEntity:
          Name:
            NameFull: van der Heide UA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-355X
          Numbering:
            – Type: volume
              Value: 125
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: International journal of radiation oncology, biology, physics
              Type: main
ResultId 1